Sero-epidemiologic study of hepatitis C virus infection in Fukuoka, Japan

Sata, Michio; Nakano, Hitoshi; Suzuki, Hiroshi; Noguchi, Seiji; Yamakawa, Yohsuke; Tanaka, Eisuke; Fukuizumi, Kunitaka; Tanaka, Kumi; Yoshida, Hiroshi; Tanikawa, Kyuichi; Sata, M; Nakano, H; Suzuki, H; Noguchi, S; Yamakawa, Y; Tanaka, E; Fukuizumi, K; Tanaka, K; Yoshida, H; Tanikawa, K
April 1998
Journal of Gastroenterology;1998, Vol. 33 Issue 2, p218
Academic Journal
journal article
We conducted an epidemiological study of 509 residents of H town, Fukuoka, Japan, to investigate the high mortality rate from liver disease. Antibodies to hepatitis C virus (HCV) (anti-HCV) were detected in 120 residents (23.6%); HCV RNA in 91 (17.9%), and hepatitis B surface antigen (HBsAg) in 13 (2.6%). Multivariate logistic regression analyses showed that presence of anti-HCV, male gender, and history of liver disease were associated with the presence of liver dysfunction, and that age of more than 40 years and a particular district were associated with the presence of anti-HCV. HCV RNA was more frequently detected in anti-HCV-positive men than women (41, or 85.4% versus 50, or 69.4%) (P < 0.05). The incidence of liver dysfunction was significantly higher in HCV RNA-positive men than women (32, or 66.7% versus 22, or 30.6%) (P < 0.05). These findings suggest that: (1) HCV was correlated with the high mortality rate from liver diseases, (2) there were district-related differences in the incidence of HCV, and (3) the lower frequency of elimination of HCV from men may explain why they showed a high mortality from liver disease.


Related Articles

  • Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin. Macías, Juan; Del Valle, José; Rivero, Antonio; Mira, José A.; Camacho, Ángela; Merchante, Nicolás; Pérez-Camacho, Inés; Neukam, Karin; Rivero-Juárez, Antonio; Mata, Rosario; Torre-Cisneros, Julián; Pineda, Juan A. // Journal of Antimicrobial Chemotherapy (JAC);Oct2010, Vol. 65 Issue 10, p2204 

    Objectives: To evaluate the changes in liver stiffness measurement (LSM) in patients infected by hepatitis C virus (HCV) under pegylated interferon (Peg-IFN) plus ribavirin therapy.

  • Liver-specific case fatality due to chronic hepatitis C virus infection: a systematic review. Szabo, Shelagh M.; Samp, Jennifer C.; Walker, David R.; Lane, Suzanne; Cline, Stephanie K.; Gooch, Katherine L.; Jimenez-Mendez, Ricardo; Levy, Adrian R. // Annals of Hepatology: Official Journal of the Mexican Associatio;Sep/Oct2015, Vol. 14 Issue 5, p618 

    Despite reports that mortality is increasing, overall case fatality due to hepatitis C virus (HCV) is thought to be low. Given the variability in published rates, we aimed to synthesize estimates of liver-specific case fatality and all-cause mortality in chronic HCV according to follow-up...

  • Alcoholic Liver Disease-Related Mortality in the United States: 1980–2003. Paula, Helga; Asrani, Sumeet K.; Boetticher, Nicholas C.; Pedersen, Rachel; Shah, Vijay H.; Kim, W. Ray // American Journal of Gastroenterology;Aug2010, Vol. 105 Issue 8, p1782 

    OBJECTIVES:Data on temporal changes in alcoholic liver disease (ALD)-related mortality in the United States are lacking. This longitudinal assessment is important, given the divergent data on trends in worldwide ALD-related mortality, concerns for underestimation of mortality attributed to ALD...

  • All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population. El-Kamary, Samer S.; Jhaveri, Ravi; Shardell, Michelle D. // Clinical Infectious Diseases;7/15/2011, Vol. 53 Issue 2, p150 

    Background. Liver-related mortality among those infected with hepatitis C virus (HCV) has been described, but little is known about non-liver-related mortality. Our objective was to determine HCV-associated all-cause, liver-, and non-liver-related mortality in the general US population. Methods....

  • Gene expression and hepatitis C virus infection. T Asselah // Gut;Jun2009, Vol. 58 Issue 6, p846 

    Hepatitis C virus (HCV) is a major cause of chronic liver disease, with about 170 million people infected worldwide. Up to 70% of patients will have persistent infection after inoculation, making this disease a significant cause of morbidity and mortality. The severity of disease varies widely,...

  • Clinical digest. People with hepatitis at higher risk of death from range of causes.  // Nursing Standard;8/3/2011, Vol. 25 Issue 48, p16 

    The article reports on research on hepatitis which was reported in a 2011 issue of the periodical "Clinical Infectious Diseases" and found that people with chronic hepatitis C virus infection are at a higher risk of death from a variety of causes than uninfected people.

  • A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. McDonald, Scott A.; Hutchinson, Sharon J.; Bird, Sheila M.; Mills, Peter R.; Dillon, John; Bloor, Mick; Robertson, Chris; Donaghy, Martin; Hayes, Peter; Graham, Lesley; Goldberg, David J. // Statistical Methods in Medical Research;Jun2009, Vol. 18 Issue 3, p271 

    Infection with the hepatitis C virus (HCV) is known to increase the risk of death from severe liver disease and, because HCV status is strongly associated with a history of injecting drug use, the effect of a key disease progression cofactor, infection with human immunodeficiency virus (HIV), is...

  • Hepatitis C virus infection in end stage renal disease and after kidney transplant. Rodriguez-Castro, Kryssia Isabel; Morisco, Filomena; Rigotti, Paolo; Rugge, Massimo; Burra, Patrizia // Journal of Gastrointestinal & Liver Diseases;Sep2014, Vol. 23 Issue 3, p240 

    A letter to the editor is presented which discusses the study on the impact of hepatitis C virus (HCV) in patients with liver disease and who undergo kidney transplantation (KT).

  • HCV-Infected ESRD Patients at Increased Risk of Death.  // Kidney;Mar/Apr99, Vol. 8 Issue 2, p72 

    Presents an abstract of the study 'Risk of death among chronic dialysis patients infected with hepatitis C virus,' by C.O. Stehman-Breen, S. Emerson, D. Gretch, et al.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics